The goal should be evidence, oversight, and access in that order, without sacrificing any of the three
:13 L-carnitine
Spending on glucagon-like peptide-1 receptor agonists among US adults, JAMA Network Open (2025) H.R.4818 treat and reduce obesity act of 2023, Congress.gov (2023) Anti-obesity drugs will not be covered by Medicare and Medicaid in 2026, American College of Gastroenterology (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Combined with encryption and third-party audits, these safeguards keep personal and financial data protected without adding unnecessary hurdles
Accessed June 26, 2023, Abdel-Malek M, Yang L, Miras AD
More receptors does not mean a better research tool when the protocol requires receptor-specific attribution